Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1025.0000 (2.5%) ($1025.0000 - $1025.0000) on Tue. May. 8, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 44.12% (three month average) | RSI | 0 | Latest Price | $1025.0000(2.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) GLD(3%) XLP(3%) EWG(2%) LQD(2%) SHY(2%) | Factors Impacting CAPR price | CAPR will decline at least -22.06% in a week (0% probabilities). USO(-1%) XOP(-0%) XLK(-0%) QQQ(0%) IWM(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -22.06% (StdDev 44.12%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $1005(1.99%) | 10 Day Moving Average | $1002.75(2.22%) | 20 Day Moving Average | $1001.38(2.36%) | To recent high | -21.9% | To recent low | 720% | Market Cap | $20.19b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |